81626Y0764-QIAGEN REQUIREMENT CONTRACT 26ME017

The Office of the Chief Medical Examiner (OCME) intends to enter into a sole source agreement with Qiagen LLC for Qiagen reagents' supplies and forensic genomics equipment, supplies, and services. The contract is expected to start on November 1, 2026, and end on October 31, 2031. The OCME is seeking a vendor who can provide these goods and services. • The contract includes various Qiagen products, such as QIAGEN-tip, QIAGEN Genomic-tip, and QIAGEN Plasmid Mini Kit. • The vendor must be capable of providing the required goods and services to the NYC Office of the Chief Medical Examiner. • The contract has a duration of approximately 5 years.